
    
      Patients with Inflammatory Bowel Disease (IBD), disease in remission and chronic fatigue will
      receive high dose oral Thiamine treatment for 4 weeks in a RCT, cross-over study.

      After the high dose treatment period, participants will be randomized to 3 months treatment
      with Thiamine 300mg/day or placebo.
    
  